Katherine Ward - Eco14: Patient Safety

Transcript

1. The rise of the Medical Selfie: Using the smart phone camera to improve patient pathways Katherine Ward Chief Commercial Officer Managing Director, UNITED KINGDOM & EUROPE NATIONAL HEALTH SERVICE INNOvation Accelerator Fellow 2. Confidential Testing at home with no quality compromise 3. Confidential •Successfully digitised diagnostics through unique computer vision and user centric design •Growing product portfolio across urinalysis, urine albumin testing and wound assessment •White label technology partner to existing healthcare players, unlocking digital potential in established patient groups •Three years from idea through successful clinical trials to global sales •Closed $12 million funding round to expand product line and commercial activities •Award winning and experienced global leadership team (World Economic Forum 2016 Tech Pioneers) A clinical reality… The Rise of the Medical Selfie: Healthy.io leverages built-in smartphone cameras to save doctor and patient time” “ 4. Confidential New digital UTI pathway for people with MS UK Clinical Reality •£40 million admission cost •4% of people with MS will be admitted because of a UTI •5 million GP appointments for UTI total Clinical Evidence; Partners •NeuroResponse & UCLH •Digital pathway for people with MS •Integrated solution 5. Confidential Prenatal care - rolled out in at risk pregnancies UK Clinical Reality •15% of pregnancies have hypertension •2nd leading cause of infant death •Visual reading high false negative rate •£1,500 additional cost per false negative Clinical Evidence; Partners •150 person study at Johns Hopkins •90% favourability •20,000 people roll out with Meuhedet 6. Confidential Improving quality for high risk pregnancy 7. Confidential Robust favourability among pregnant women for home urinalysis testing In a clinical study conducted between May and August 2017, 150 pregnant women were provided with the Dip.io smartphone urinalysis kit and asked to perform the test at home a morning after their routine point of care urinalysis. The study aimed to assess usability across multiple platforms and measure process favourability. <10% Prefer lab testing at dip.io 8.2/10* Satisfaction rank 97% Described the process as easy 98% Usability success 8. Confidential Pathway #1 Diabetes 9 Care Processes •51% adherence to guidelines (Type 1 Diabetics) •1,000,000 People unaware of their CKD •£1.5bn Annual ESRD cost •NICE QS 05 and NICE CG 182 •US NKF and the Geisinger HMO group under Professor Joe Coresh of Hopkins •DNKF and Professor Gansevoort •Early stage partnership, Modality UK Clinical Reality Clinical Evidence; Partners 9. Confidential katherine@healthy. io 07971386718